Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
  • Portal Login
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
  • Portal Login

Understanding the Short-Lived Immunity of COVID-19 mRNA Vaccines: Challenges and Future Directions

  • October 30, 2024
  • Posted by: OptimizeIAS Team
  • Category: DPN Topics
No Comments

 

 

Understanding the Short-Lived Immunity of COVID-19 mRNA Vaccines: Challenges and Future Directions

Sub : Sci

Sec: Health

Why in News

COVID-19 mRNA vaccines have been groundbreaking, yet concerns are growing regarding the rapid decline in their effectiveness. Recent studies are shedding light on why these vaccines may not produce the long-lasting immunity seen in other vaccines. This article explores these findings and delves into the mechanisms behind vaccine-induced immunity, focusing on the role of long-lasting plasma cells (LLPCs) and implications for future vaccine development.

Rapid Waning of Immunity:

COVID-19 vaccines, especially mRNA-based ones, have shown a faster decline in immunity compared to many traditional vaccines. The main reason for this decline appears to be the lack of LLPCs in the bone marrow, which are essential for prolonged antibody production.

About Long-Lasting Plasma Cells (LLPCs):

LLPCs are vital for long-term immunity as they continuously produce antibodies against specific antigens, even without repeated exposure, contributing to lasting protection against diseases.

They develop from activated B-cells in structures called germinal centres found within lymph nodes and the spleen, a process often involving helper T-cells that aid in the maturation and specialization of these plasma cells.

After their formation, LLPCs migrate to bone marrow “niches” where they receive essential survival signals from surrounding stromal cells and factors like APRIL (A Proliferation-Inducing Ligand), allowing them to remain functional for years or even decades.

For effective vaccines, LLPCs are key as they provide the durable antibody response needed to prevent re-infection. However, not all vaccines successfully induce LLPCs, which is a focus of ongoing research for enhancing vaccine durability.

Distinction from Short-Lived Plasma Cells (SLPCs): Unlike SLPCs, which provide an immediate, short-term antibody response and then die off, LLPCs can maintain an antibody response over long periods without needing to re-encounter the antigen.

About Bone Marrow Niches: These specialized environments provide crucial cytokines and other factors that ensure LLPCs remain active and functional, a process essential to long-lasting immunity. Researchers are investigating ways to mimic these niches in vaccine designs to create more enduring immune responses.

Findings on COVID-19 Vaccine-Induced LLPCs:

A study published in Nature Medicine examined LLPCs in individuals who had received COVID-19 mRNA vaccines.

LLPCs were compared for COVID-19, influenza, and tetanus vaccines. COVID-19 vaccine-induced LLPCs were significantly lower than those for influenza and tetanus, indicating shorter immunity duration.

IgG and IgA Analysis: Antibody-secreting cells specific to different immunoglobulins (IgG and IgA) echoed these results, showing a deficiency in COVID-19-specific LLPCs.

About Antibody:

Antibody, also called immunoglobulin, is a Y shaped protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen.

Antibodies recognize and attack onto antigens in order to remove them from the body.

Each tip of the “Y” of an antibody contains a paratope (analogous to a lock) that is specific for one particular epitope (analogous to a key) on an antigen, allowing these two structures to bind together with precision.

Using this binding mechanism, an antibody can tag a microbe or an infected cell and can neutralize it directly.

The main types of antibodies (immunoglobulins) include:

IgG. These are the most abundant types of antibodies in your plasma. They detoxify harmful substances and provide long-term protection.

IgM. These are the first antibodies made by B cells in response to antigens.

IgA. These antibodies collect antigens and remove them from your body in your mucus or other body fluids.

IgE. These antibodies trigger allergies and protect against parasites. Small amounts are in your skin, lungs, and mucosal membranes.

IgD. These antibodies bind to B cells and signal them to release IgM antibodies.

The Role of SARS-CoV-2 Spike Protein Structure

The SARS-CoV-2 virus has spikes spaced around 20–25 nanometres apart, which may hinder B-cell receptor (BCR) cross-linking—a process vital for generating LLPCs.

COVID-19 mRNA vaccines rely heavily on this spike protein as the primary immunogenic element. This spacing may partially explain why immunity from these vaccines fades more quickly.

Some researchers remain sceptical, suggesting spike spacing might not fully account for the lack of LLPCs, indicating that other factors could contribute to the waning immunity.

Science and tech Understanding the Short-Lived Immunity of COVID-19 mRNA Vaccines: Challenges and Future Directions

Recent Posts

  • Daily Prelims Notes 23 March 2025 March 23, 2025
  • Challenges in Uploading Voting Data March 23, 2025
  • Fertilizers Committee Warns Against Under-Funding of Nutrient Subsidy Schemes March 23, 2025
  • Tavasya: The Fourth Krivak-Class Stealth Frigate Launched March 23, 2025
  • Indo-French Naval Exercise Varuna 2024 March 23, 2025
  • No Mismatch Between Circulating Influenza Strains and Vaccine Strains March 23, 2025
  • South Cascade Glacier March 22, 2025
  • Made-in-India Web Browser March 22, 2025
  • Charting a route for IORA under India’s chairship March 22, 2025
  • Mar-a-Lago Accord and dollar devaluation March 22, 2025

About

If IAS is your destination, begin your journey with Optimize IAS.

Hi There, I am Santosh I have the unique distinction of clearing all 6 UPSC CSE Prelims with huge margins.

I mastered the art of clearing UPSC CSE Prelims and in the process devised an unbeatable strategy to ace Prelims which many students struggle to do.

Contact us

moc.saiezimitpo@tcatnoc

For More Details

Work with Us

Connect With Me

Course Portal
Search